ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,034Medicare Part D Prescriptions Filled, Including Refills

Rank: 88 out of 1206

$535K Total Retail Price of All Prescriptions

Rank: 135 out of 1206

622 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 622 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 622 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 10,987 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 721 618 1 1
LEVOTHYROXINE SODIUM 704 617 2 2
OMEPRAZOLE 581 496 3 3
AMLODIPINE BESYLATE 424 410 4 6
LISINOPRIL 355 301 5 4
METFORMIN HCL 321 243 6 10
METOPROLOL TARTRATE 294 273 7 9
FUROSEMIDE 287 259 8 5
METOPROLOL SUCCINATE 276 268 9 15
TRAMADOL HCL 261 230 10 17
CITALOPRAM HBR 256 238 11 16
GABAPENTIN 235 184 12 18
POTASSIUM CHLORIDE 234 185 13 12
ATENOLOL 219 186 14 14
HYDROCHLOROTHIAZIDE 219 200 14 11
WARFARIN SODIUM 197 178 16 8
ENALAPRIL MALEATE 182 169 17 45
HYDROCODONE-ACETAMINOPHEN 162 125 S3 18 7
TRIAMTERENE-HCTZ 160 144 19 33
RANITIDINE HCL 141 95 20 23
POLYETHYLENE GLYCOL 3350 138 118 21 31
DIOVAN 129 121 22 57
ATORVASTATIN CALCIUM 127 121 23 13
ZOLPIDEM TARTRATE 125 107 24 25
PREDNISONE 120 101 25 28
LOSARTAN POTASSIUM 114 114 26 20
ALLOPURINOL 114 103 26 24
TAMSULOSIN HCL 110 110 28 26
DONEPEZIL HCL 109 108 29 29
CLOPIDOGREL 108 105 30 48
ALENDRONATE SODIUM 105 100 31 19
FLUTICASONE PROPIONATE 97 83 32 42
MIRTAZAPINE 94 90 33 50
AMITRIPTYLINE HCL 91 91 R 34 59
PANTOPRAZOLE SODIUM 89 76 35 54
PLAVIX 83 80 36 72
GLIMEPIRIDE 83 80 36 34
ADVAIR DISKUS 82 60 38 55
AMLODIPINE BESYLATE-BENAZEPRIL 81 75 39 76
GLYBURIDE 81 67 R 39 69
SERTRALINE HCL 80 71 41 22
LEVETIRACETAM 76 54 42 135
LOVASTATIN 76 65 42 44
SPIRONOLACTONE 75 59 44 41
LANTUS 73 33 45 38
BENAZEPRIL HCL 70 62 46 39
DOXYCYCLINE HYCLATE 63 43 47 103
PRAVASTATIN SODIUM 63 63 47 21
PROAIR HFA 61 46 49 49
KLOR-CON M20 60 55 50 126
CYCLOBENZAPRINE HCL 56 23 R 51 80
RISPERIDONE 54 44 52 74
ZETIA 54 53 52 73
OXYBUTYNIN CHLORIDE 53 52 54 68
PAROXETINE HCL 53 41 54 53
NEXIUM 53 31 54 47
NAMENDA 52 52 57 36
LEVOFLOXACIN 51 41 58 78
CARBIDOPA-LEVODOPA 50 50 59 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 26, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.